Age at development of type 1 diabetes-and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth

Diabetes Care

Volumn 33, Issue 4, 2010, Pages 774-779

  Simell, Satu ^a,b   Hoppu, Sanna ^a,c   Simell, Tuu ^a,b   Ståhlberg, Marja Riitta ^b   Viander, Markku ^b   Routi, Taina ^b   Simell, Ville ^a,b   Veijola, Riitta ^a,d   Ilonen, Jorma ^a,b,e   Hyöty, Heikki ^a,f   Knip, Mikael ^a,c,g   Simell, Olli ^a,b  

^a Juvenile Diabetes Research Foundation International   (United States)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; PROTEIN TYROSINE PHOSPHATASE RELATED IA 2 PROTEIN AUTOANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; ONSET AGE; PRESCHOOL CHILD; RISK FACTOR; SEROCONVERSION;

AGE OF ONSET; AUTOANTIBODIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE;

EID: 77953072611     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1217     Document Type: Article

References (25)

1. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, Lohi O, Bravi E, Gasparin M, Reunanen A, Mäki M. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007;26: 1217-1225
2. Holmes GK. Screening for coeliac disease in type 1 diabetes. Arch Dis Child 2002; 87:495-498
3. Savilahti E, Simell O, Koskimies S, Rilva A, Åkerblom HK. Celiac disease in insulin-dependent diabetes mellitus. J Pediatr 1986;108:690-693 (Pubitemid 16064110)
4. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359:2767-2777
5. Simell S, Hoppu S, Hekkala A, Simell T, Ståhlberg MR, Viander M, Yrjänäinen H, Grönlund J, Markula P, Simell V, Knip M, Ilonen J, Hyöty H, Simell O. Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. Am J Gastroenterol 2007; 102:2026-2035
6. Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F, Bianchi C, Chiumello G. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002;109:833-838
7. Larsson K, Carlsson A, Cederwall E, Jönsson B, Neiderud J, Jonsson B, Lernmark A, Ivarsson SA, Skåne Study Group. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes 2008;9:354-359
8. Cronin CC, Shanahan F. Insulin-dependent diabetes mellitus and coeliac disease. Lancet 1997;349:1096-1097
9. Williams AJ, Norcross AJ, Lock RJ, Unsworth DJ, Gale EA, Bingley PJ. The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity. Diabetes Care 2001;24:504-509
10. Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE, Emery LM, Sokol RJ, Erlich HA, Eisenbarth GS, Rewers M. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005;293:2343-2351
11. Hummel M, Bonifacio E, Stern M, Dittler J, Schimmel A, Ziegler AG. Development of celiac disease-associated antibodies in offspring of parents with type I diabetes. Diabetologia 2000;43:1005-1011
12. Hummel S, Hummel M, Banholzer J, Hanak D, Mollenhauer U, Bonifacio E, Ziegler AG. Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia 2007;50:390-394
13. Kupila A, Muona P, Simell T, Arvilommi P, Savolainen H, Hämäläinen AM, Korhonen S, Kimpimäki T, Sjöroos M, Ilonen J, Knip M, Simell O, Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001;44:290-297
14. Nejentsev S, Sjö roos M, Soukka T, Knip M, Simell O, Lövgren T, Ilonen J. Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLADRB1 loci. Diabet Med 1999;16:985-992
15. Kukko M, Kimpimäki T, Korhonen S, Kupila A, Simell S, Veijola R, Simell T, Ilonen J, Simell O, Knip M. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2005;90:2712-2717
16. World Health Organization/Department of Noncommunicable Disease Surveillance. Part 1: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva, Switzerland, World Health Org., 1999
17. Kupila A, Keskinen P, Simell T, Erkkilä S, Arvilommi P, Korhonen S, Kimpimäki T, Sjöroos M, Ronkainen M, Ilonen J, Knip M, Simell O. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 2002;51:646-651 (Pubitemid 34760171)
18. Simell S, Kupila A, Hoppu S, Hekkala A, Simell T, Ståhlberg MR, Viander M, Hurme T, Knip M, Ilonen J, Hyöty H, Simell O. Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol 2005;40:1182-1191
19. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994;35:776-778 (Pubitemid 24193220)
20. Mäki M, Hällström O, Vesikari T, Visakorpi JK. Evaluation of a serum IgA-class reticulin antibody test for the detection of childhood celiac disease. J Pediatr 1984; 105:901-905
21. Savilahti E, Viander M, Perkkiö M, Vainio E, Kalimo K, Reunala T. IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease. Lancet 1983;1:320-322 (Pubitemid 13189170)
22. Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, Rewers M. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290:1713-1720
23. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003;290: 1721-1728
24. Siljander HT, Simell S, Hekkala A, Lähde J, Simell T, Vähäsalo P, Veijola R, Ilonen J, Simell O, Knip M. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 2009;58:2835-2842
25. Ankelo M, Kleimola V, Simell S, Simell O, Knip M, Jokisalo E, Tarkia M, Westerlund A, He Q, Viander M, Ilonen J, Hinkkanen AE. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Clin Exp Immunol 2007;150:285-293